1975-1989

  1. C. Pace-Asciak and S. Cole. Inhibitors of prostaglandin catabolism. I. Differential sensitivity of 9-PGDH, 13-PGR and 15-PGDH to low concentrations of indomethacin. Experientia 31: 143-145 (1975).
  2. S.P.C. Cole, E.J. Vavasour and G.S. Marks. Drug-induced porphyrin biosynthesis. XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an inhibitor of ferrochelatase. Biochem. Pharmacol. 28: 3533-3538 (1979).
  3. S.P.C. Cole and G.S. Marks. Structural requirements in dihydropyridines for ferrochelatase inhibition and -aminolevulinic acid synthetase induction. Int. J. Biochem. 12: 989-992 (1980).
  4. P.R. Ortiz de Montellano, K.L. Kunze, S.P.C. Cole and G.S. Marks. Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX. Biochem. Biophys. Res. Commun. 97: 1436-1442 (1980).
  5. S.P.C. Cole, D.T. Zelt and G.S. Marks. Comparison of the effects of griseofulvin and 3, 5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in the chick embryo liver. Molec. Pharmacol. 19: 477-480 (1981).
  6. S.P.C. Cole, R.A. Whitney and G.S. Marks. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6- trimethylpyridine and its analogues in chick embryo liver cells. Molec. Pharmacol. 20: 395-403 (1981).
  7. S.P.C. Cole, T.E. Massey, G.S. Marks and W.J. Racz. Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes. Can. J. Physiol. Pharmacol. 59: 1155-1158 (1981).
  8. P.R. Ortiz de Montellano, K.L. Kunze, S.P.C. Cole and G.S. Marks. Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylprotoporphyrin IX. Biochem. Biophys. Res. Commun. 103: 581-586 (1981).
  9. S.P.C. Cole, G.S. Marks, P.R. Ortiz de Montellano and K.L. Kunze. Inhibition of ferrochelatase by N-methylprotoporphyrin IX is not accompanied by -aminolevulinic acid synthetase induction in chick embryo liver cell culture. Can. J. Physiol. Pharmacol. 60: 212-215 (1982).
  10. G.S. Marks, D.T. Zelt and S.P.C Cole. Alterations in the heme biosynthetic pathway as an index of exposure to toxins. Can. J. Physiol. Pharmacol. 60: 1017-1026 (1982).
  11. S.P.C. Cole and G.S. Marks. A radiochemical assay for heme synthase activity; confirmation and supplement. Enzyme 28: 231-232 (1982).
  12. G.S. Marks, S.B. Follows, D.T. Zelt and S.P.C. Cole. Patterns of porphyrin accumulation in response to chemicals in chick embryo liver cells. Can. J. Physiol. Pharmacol. 61: 546-553 (1983).
  13. S.P.C. Cole, B.G. Campling, T. Atlaw, D. Kozbor and J.C. Roder. Human monoclonal antibodies. Molec. Cell. Biochem. 62: 109-120 (1984).
  14. S.P.C. Cole, B.G. Campling, I.H. Louwman, D. Kozbor and J.C. Roder. A strategy for the production of human monoclonal antibodies reactive with lung tumor cells. Cancer Res. 44: 2750-2753 (1984).
  15. S.P.C. Cole and G.S. Marks. Ferrochelatase and N-alkylated porphyrins. Molec. Cell. Biochem. 64: 127-137 (1984).
  16. S.P.C. Cole, E.H. Vreeken and J.C. Roder. Antibody production by human x human hybridomas in serum-free medium. J. Immunol. Meth. 78: 271-278 (1985).
  17. J.C. Roder, D. Kozbor, S.P.C. Cole, T. Atlaw, B.G. Campling and R.C. McGarry. The EBV-hybridoma technique. In, Human Hybridomas and Monoclonal Antibodies (eds. E.G. Engleman, S. Foung, J. Larrick, A. Raubitschek), Chapter 4, pp. 55-70, Plenum Press, N.Y., 1985.
  18. S.P.C. Cole, S. Mirski, R.C. McGarry, R. Cheng, B.G. Campling and J.C. Roder. Differential expression of Leu-7 antigen on human lung tumor cells. Cancer Res. 45: 4285-4290 (1985). (RM460)
  19. S.P.C. Cole, D. Kozbor and J.C. Roder. Strategies for production of human monoclonal antibodies. In, Hybridoma Technology in the Biosciences and Medicine (ed. T.A. Springer), Chapter 2, pp. 43-55, Plenum Press, N.Y., 1985.
  20. D. Kozbor, W. Abramow-Newerly, P. Tripputi, S.P.C. Cole, J. Weibel, J.C. Roder and C.M. Croce. Specific immunoglobulin production and enhanced tumorigenicity following ascites growth of human hybridomas. J. Immunol. Meth. 81: 31-42 (1985).
  21. S.P.C. Cole, D. Kozbor and J.C. Roder. The EBV-hybridoma technique and its application to human lung cancer. In, Monoclonal Antibodies and Cancer Therapy (Vol. 27, UCLA Symposia on Molecular and Cellular Biology, New Series) (eds. R.A. Reisfeld and S.Sell), pp. 77-96, Alan R. Liss, Inc. N.Y., 1985.
  22. A.C. Peacock, S.L. Bunting, S.P.C. Cole and M. Seidman. Two dimensional electrophoretic display of restriction fragments from genomic DNA. Analyt. Biochem. 149: 177-182 (1985).
  23. S.P.C. Cole, B.G. Campling, D.F. Dexter, J.J.A. Holden and J.C. Roder. Establishment of a human large cell lung tumor line (QU-DB) with metastatic properties in athymic mice. Cancer 58: 917-923 (1986).
  24. J.C. Roder, S.P.C. Cole and D. Kozbor. The EBV-hybridoma technique. In, Immunochemical Techniques (eds. J.J. Langone and H. Van Vunakis), Meth. Enzymol. 121: 140-167, Academic Press, N.Y., 1986.
  25. D. Kozbor, J.C. Roder, M.E. Sierzega, S.P.C. Cole and C.M. Croce. Comparative phenotypic analysis of available hybridoma fusion partners. In, Immunochemical Techniques (eds. J.J. Langone and H. Van Vunakis), Meth. Enzymol. 121: 120-140, Academic Press, N.Y., 1986.
  26. S.P.C. Cole. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother. Pharmacol. 17: 259-263 (1986).
  27. P.G. Forkert, M.L. Vessey, J.S. Elce, S.S. Park, H.V. Gelboin and S.P.C. Cole. Localization of phenobarbital- and 3-methylcholanthrene- inducible cytochromes P-450 in mouse lung with monoclonal antibodies. Res. Commun. Chem. Pathol. Pharm. 53: 147-157 (1986).
  28. B.G. Campling, S.P.C. Cole, T. Atlaw, D. Kozbor and J.C. Roder. The EBV-hybridoma technique and its applications. In, Human Hybridomas: Diagnostic and Therapeutic Applications (ed. A.J. Strelkauskas), Chapter 1, pp. 3-22, Marcel-Dekker, N.Y., 1986.
  29. B.G. Campling, S.P.C. Cole, T. Atlaw, D. Kozbor and J.C. Roder. Practical aspects of human-human hybridomas. In, Monoclonal Antibodies: Production, Techniques and Applications (ed. L.B. Schook), Chapter 1, pp. 3-23, Marcel-Dekker, N.Y., 1987.
  30. S.P.C. Cole. Monoclonal antibodies. Can. Fam. Physician 33: 369-372 (1987).
  31. S.P.C. Cole, E.H. Vreeken, S.E.L. Mirski and B.G. Campling. Growth of human x human hybridomas in protein-free medium supplemented with ethanolamine. J. Immunol. Meth. 97: 29-35 (1987).
  32. S.E.L. Mirski, J.H. Gerlach and S.P.C. Cole. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res. 47: 2594-2598 (1987).
  33. J.M. Trent, P.S. Meltzer, M.L. Slovak, A.B. Hill, W.S. Dalton, W.T. Beck and S.P.C. Cole. Cytogenetic and molecular biologic alterations associated with anthracycline resistance. In, Mechanisms of Drug Resistance in Neoplastic Cells (eds. P.V. Woolley and K.D. Tew), Vol. 9, Chapter 17, pp. 259-276, Academic Press, N.Y., 1988.
  34. B.G. Campling, J. Pym, P.R. Galbraith and S.P.C. Cole. Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leukemia Res. 12: 823-831 (1988).
  35. S.P.C. Cole, H.F. Downes and M.L. Slovak. Effect of calcium antagonists on the chemosensitivity of two multidrug resistant human tumour cell lines which do not overexpress P-glycoprotein. Br. J. Cancer 59: 42-46 (1989).
  36. P.G. Forkert, M.L. Vessey, S.S. Park, H.V. Gelboin and S.P.C. Cole. Cytochromes P-450 in murine lung: an immunohistochemical study with monoclonal antibodies. Drug Metab. Disp. 17: 551-555 (1989).
  37. S.E.L. Mirski and S.P.C. Cole. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line. Cancer Res. 49: 5719-5724 (1989).